Therapeutic approaches to neonatal jaundice: An international survey

Clinical Pediatrics

Volumn 35, Issue 6, 1996, Pages 309-316

  Hansen, Thor Willy Ruud ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; EXCHANGE BLOOD TRANSFUSION; FLUID THERAPY; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; PHOTOTHERAPY; QUESTIONNAIRE; TREATMENT PLANNING;

EID: 0029936032     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289603500604     Document Type: Article

References (36)

1. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89:809-818.
2. Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics. 1992;90:707-715.
3. American Academy of Pediatrics Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94:558-565.
4. Brown AK, Seidman DS, Stevenson DK. Jaundice in healthy, term neonates: do we need new action levels or new approaches? Pediatrics. 1992;89:827-829.
5. Cashore WJ. Hyperbilirubinemia: should we adopt a new standard of care? Pediatrics. 1992;89:824-826.
6. Johnson L. Yet another expert opinion on bilirubin toxicity! Pediatrics. 1992;89:829-831.
7. Merenstein GB. 'New' bilirubin recommendations questioned. Pediatrics. 1992;89:822-823.
8. Valaes T. Bilirubin toxicity: the problem was solved a generation ago. Pediatrics. 1992;89:819-821.
9. Wennberg RP. Bilirubin recommendations. Present problems: new guidelines simplistic and untested. Pediatrics. 1992,89:821-822.
10. Moore LG, Newberry MA, Freeby GM, Crnic LS. Increased incidence of neonatal hyperbilirubinemia at 3100 m in Colorado. Am J Dis Child. 1984;138:157-161.
11. Tan KL. Glucose-6-phosphate debydrogenase status and neonatal jaundice. Arch Dis Child. 1981,56:874-877.
12. Tan KL. Neonatal jaundice in "healthy" very low birthweight infants Aust Paed J. 1987;23:185-188.
13. Yllpo A. Icterus neonatorum (incl.I.n. gravis) und Gallenfarbstotfsekretion bei Foetus und Neugeboren. Z Kinderheilk. 1913;9:208-318.
14. Plastino R, Buchner DM, Wagner EH. Impact of eligibility criteria on phototherapy program size and cost. Pediatrics. 1990;85:796-800.
15. Orth J. Ueber das Vorkommen von Bilirubinkristallen bei neugeborenen Kindern. Virchows Arch Pathol Anat. 1875;63:447-462.
16. Day RL. Inhibition of brain respiration in vitro by bilirubin: reversal of inhibition by various means. Am J Dis Child. 1954;88:504-506.
17. Zetterström R, Ernster L. Bilirubin, an uncoupler of oxidative phosphorylation in isolated mitochondria Nature. 1956;178:1335-1337.
18. Hansen TWR. Bilirubin in the brain. Distribution and effects on neurophysiological and neurochemical processes. Clin Pediatr. 1994;33:452-459.
19. Gartner LM. Management of jaundice in the well baby. Pediatrics. 1992; 89:826-827.
20. Newman TB, Maisels MJ. Response to commentaries re: evaluation and treatment of jaundice in the term newborn: a kinder, gender approach. Pediatrics. 1992;89:831-833.
21. Poland RL. In search of a 'gold standard' for bilirubin toxicity. Pediatrics. 1992;89:823-824.
22. Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled trial comparing agar, intermittent phototherapy, and continuous phototherapy for reducing neonatal hyperbilirubinemia. J Pediatr. 1973;82: 73-76.
23. Rubaltelli FF, Zanadro V, Granati B. Effects of various phototherapy regimens on bilirubin decrement. Pediatrics. 1978;61:838-841.
24. Vogl TP, Hegyi T, Hiatt M, et al. Intermittent phototherapy in the treatment of jaundice in the premature infant. J Pediatr. 1978;92:627-630.
25. Curtis-Cohen M, Stahl GE, Costarino AT, Polin RA. Randomized trial of prophylactic phototherapy in the infant with very low birth weight. J Pediatr. 1985;107:121-124.
26. Brown AK, Kim MH, Wu PYK, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985; 75:393-400.
27. Bell EF, Neidich GA, Cashore WJ, Oh W. Combined effect of radiant warmer and phototherapy on insensible water loss in low birth weight infants. J Pediatr. 1979;94:810-813.
28. Oh W, Karecki H. Phototherapy and insensible water loss in the newborn infant Am J Dis Child. 1972;124:230-232.
29. Wu PYK, Hodgman JE. Insensible water loss in preterm infants: changes with post-natal development and nonionizing radiant energy. Pediatrics. 1974;54:704-712.
30. Kjartanson S, Hammarlund K, Sedin G. Insensible water loss from the skin during phototherapy in term and preterm infants. Ada Paediatr. 1992;81:764-768.
31. Kjartanson S, Hammarlund K, Riesenfeld T, Sedin G. Respiratory water loss and oxygen consumption in newborn infants during phototherapy. Acta Paediatr. 1992;81:769-773.
32. Rûbo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr. 1991;121:93-97.
33. Maisels MJ. Neonatal jaundice. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infant. Oxford: Oxford University Press; 1992:507-561.
34. Ebbesen F, Brodersen R. Albumin administration combined with phototherapy in treatment of hyperbilirubinemia in low birth-weight infants. Acts Paediatr Scand. 1981;70: 649-653.
35. Wong YK, Shuttleworth GR, Wood BSB. Effect of albumin administration on phototherapy for neonatal jaundice. Arch Dis Child. 1971;47:241-245.
36. Hansen TWR. Bilirubin entry into and clearance from rat brain during hypercarbia and hyperosmolality. Pediatr Res. 1996;39:72-76.